Barnett PV - Search Results

1

Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents.

Parry NR, Barnett PV, Ouldridge EJ, Rowlands DJ, Brown F. Parry NR, et al. Among authors: barnett pv. J Gen Virol. 1989 Jun;70 ( Pt 6):1493-503. doi: 10.1099/0022-1317-70-6-1493. J Gen Virol. 1989. PMID: 2471812

2

Foreign epitopes in immunodominant regions of hepatitis B core particles are highly immunogenic and conformationally restricted.

Brown AL, Francis MJ, Hastings GZ, Parry NR, Barnett PV, Rowlands DJ, Clarke BE. Brown AL, et al. Among authors: barnett pv. Vaccine. 1991 Aug;9(8):595-601. doi: 10.1016/0264-410x(91)90248-5. Vaccine. 1991. PMID: 1722937

3

Host cell selection of antigenic variants of foot-and-mouth disease virus.

Bolwell C, Brown AL, Barnett PV, Campbell RO, Clarke BE, Parry NR, Ouldridge EJ, Brown F, Rowlands DJ. Bolwell C, et al. Among authors: barnett pv. J Gen Virol. 1989 Jan;70 ( Pt 1):45-57. doi: 10.1099/0022-1317-70-1-45. J Gen Virol. 1989. PMID: 2471782

4

Neutralizing epitopes of type O foot-and-mouth disease virus. I. Identification and characterization of three functionally independent, conformational sites.

Barnett PV, Ouldridge EJ, Rowlands DJ, Brown F, Parry NR. Barnett PV, et al. J Gen Virol. 1989 Jun;70 ( Pt 6):1483-91. doi: 10.1099/0022-1317-70-6-1483. J Gen Virol. 1989. PMID: 2471811

5

Serological prospects for peptide vaccines against foot-and-mouth disease virus.

Parry NR, Ouldridge EJ, Barnett PV, Clarke BE, Francis MJ, Fox JD, Rowlands DJ, Brown F. Parry NR, et al. Among authors: barnett pv. J Gen Virol. 1989 Nov;70 ( Pt 11):2919-30. doi: 10.1099/0022-1317-70-11-2919. J Gen Virol. 1989. PMID: 2479714

6

The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid).

Fox G, Parry NR, Barnett PV, McGinn B, Rowlands DJ, Brown F. Fox G, et al. Among authors: barnett pv. J Gen Virol. 1989 Mar;70 ( Pt 3):625-37. doi: 10.1099/0022-1317-70-3-625. J Gen Virol. 1989. PMID: 2543752

7

Demonstration of neutralizing and non-neutralizing epitopes on the trypsin-sensitive site of foot-and-mouth disease virus.

Ouldridge EJ, Barnett PV, Parry NR, Syred A, Head M, Rweyemamu MM. Ouldridge EJ, et al. Among authors: barnett pv. J Gen Virol. 1984 Jan;65 ( Pt 1):203-7. doi: 10.1099/0022-1317-65-1-203. J Gen Virol. 1984. PMID: 6198448

8

Monoclonal antibodies to a peptide of human rhinovirus type 2 with different specificities recognize the same minimum sequence.

Barnett PV, Rowlands DJ, Campbell RO, Parry NR. Barnett PV, et al. J Gen Virol. 1995 May;76 ( Pt 5):1255-61. doi: 10.1099/0022-1317-76-5-1255. J Gen Virol. 1995. PMID: 7730811

9

Characterization of monoclonal antibodies raised against a synthetic peptide capable of inducing a neutralizing response to human rhinovirus type 2.

Barnett PV, Rowlands DJ, Parry NR. Barnett PV, et al. J Gen Virol. 1993 Jul;74 ( Pt 7):1295-302. doi: 10.1099/0022-1317-74-7-1295. J Gen Virol. 1993. PMID: 8393073

10

The differentiation of foot and mouth disease virus strains using an indirect sandwich enzyme-linked immunosorbent assay saturation model.

Ouldridge EJ, Barnett PV, Hingley PJ, Rweyemamu MM. Ouldridge EJ, et al. Among authors: barnett pv. J Biol Stand. 1984 Oct;12(4):367-77. doi: 10.1016/s0092-1157(84)80061-x. J Biol Stand. 1984. PMID: 6098582

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters